HemoCath  logo — HemoCath™ Critical Care AI Platform – Advancing Patient Care...

HemoCath

HemoCath™ Critical Care AI Platform – Advancing Patient Care in Critical Moments

Founded 2020 United States Austin, United States 4 employees Pre-Seed Health Care, Medical Devices

General Information

Company Name HemoCath
Founded Year 2020
Location United States Austin, United States
Employees 4
Industries Health Care, Medical Devices
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with HemoCath . To contact HemoCath , visit hemocath.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does HemoCath compare?

A PDF of HemoCath and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting HemoCath soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About HemoCath

HemoCath is a Medtech and Digital Health startup that aims to revolutionize patient care in critical care and for individuals with heart failure (HF). Their AI Platform, HemoCath™, offers proactive AI-data-driven management of patients with acute HF from diagnosis to treatment, and monitoring for all hospital heart procedures. The platform consists of the HemoCath™ PA catheter connected to the Luc™ AI Cloud to continuously measure and monitor PAP & CVP, the leading indicators of heart congestion, enabling early targeted therapy. This critical health data supports optimal dosing of guideline-directed medical therapy (GDMT) across the entire spectrum of HF. With several clinical trials showing evidence of significant improvement in cardiac care and reduction in hospital stay, HemoCath has demonstrated the effectiveness of PAP-guided HF management. Founded in 2014 and headquartered in the United States, HemoCath is positioning itself at the forefront of innovation in Health Care and Medical Devices. Currently, there is no information available about their last investment or the investors involved.

No funding data available for HemoCath yet.

HemoCath Alternatives & Competitors

View All Alternatives
HemoCath vs

The future of biomonitoring

Corporate Round
24 employees
Health Care, Life Sciences
HemoCath vs

AI Cardiac Remote Monitoring

Venture round
128 employees
AI, Health Care
HemoCath vs
iMEDRIX INC.
iMEDRIX INC. United States

MOBILE - CONNECTED CARDIAC CARE. ANYTIME. ANYWHERE.

25 employees
Health Care, Medical Devices

FAQ About HemoCath

HemoCath™ Critical Care AI Platform – Advancing Patient Care in Critical Moments
HemoCath was founded in 2020.
HemoCath is headquartered in Austin, United States.
HemoCath operates in Health Care and Medical Devices.
HemoCath has approximately 4 employees.
Top alternatives and competitors to HemoCath include Onalabs Inno-Hub, Implicity, iMEDRIX INC., Prolira - DeltaScan® , ivWatch, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
HemoCath and Onalabs Inno-Hub are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for HemoCath , https://bouncewatch.com/company/hemocath, updated 8 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes